Sonographic response in the liver and urinary bladder of children 14 months after treatment for schistosomiasis

Tropical Doctor

Volumn 43, Issue 2, 2013, Pages 71-74

  Strahan, Rodney ^a   Mcadam, David ^a   Schneider, Michal E ^b  

^a Chitokoloki Mission Hospital   (Zambia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Africa; digestive; Schistosomiasis; treatment; urologic

Indexed keywords

PRAZIQUANTEL;

ADOLESCENT; ADULT; ARTICLE; BLADDER INJURY; CHILD; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; KIDNEY INJURY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHISTOSOMIASIS;

AFRICA; DIGESTIVE; SCHISTOSOMIASIS; TREATMENT; UROLOGIC;

ADOLESCENT; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; HUMANS; LIVER; LIVER DISEASES, PARASITIC; PRAZIQUANTEL; SCHISTOSOMIASIS; URINARY BLADDER; URINARY BLADDER DISEASES; YOUNG ADULT;

EID: 84880398075     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1177/0049475513490422     Document Type: Article

References (10)

1. Greyseels B, Mbaye A, De Vlas SJ et al. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 2001; 6: 864-873.
2. Utzinger J, N’Goran EK, N’Dri A et al. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health 2000; 5: 771-778.
3. Cota GF, Pinto-Silva RA, Antunes CMF et al. Ultrasound and clinical investigation of hepatosplenic schistosomiasis: evaluation of splenomegaly and liver fibrosis four years after mass chemotherapy with Oxamniquine. Am J Trop Med Hyg 2006; 74: 103-107.
4. Burchard GD, Guisse-Sow F, Diop M et al. Schistosoma mansoni infection in a recently exposed community in Senegal: lack of correlation between liver morphology in ultrasound and connective tissue metabolites in serum. Trop Med Int Health 1998; 3: 234-241.
5. Richter J, Hatz C, Campagne G, et al., eds. Ultrasound in Schistosomiasis: a Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-related Morbidity. Geneva: World Health Organization. http://whqlibdoc.who.int/hq/2000/TDR_STR_SCH_00.1.pdf (accessed 20 August 2012).
6. King CH, Magak P, Salam EA et al. Measuring morbidity in Schistosoma mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health 2003; 8: 109-117.
7. Berhe N, Geitung JT, Medhin G et al. Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia. Trop Med Int Health 2006; 11: 1286-1294.
8. Berhe N, Myrvang B, Gundersen SG. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg 2008; 78: 228-234.
9. Ruiz-Guevara R, de Noya BA, Valero SK et al. Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients. Rev Soc Brasileira Med Trop 2007; 40: 505-511.
10. Black CL, Steinauer ML, Mwinzi PNM et al. Impact of intense, longitudinal retreatment with praziquantel on cure rates of Schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Trop Med Int Health 2009; 14: 450-457.